The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A single-arm, open-label, U.S. expanded access study of vemurafenib in patients with metastatic melanoma.
Lynn Mara Schuchter
Research Funding - Roche
Lawrence E. Flaherty
Consultant or Advisory Role - Roche/Genentech
Honoraria - Roche/Genentech
Research Funding - Roche/Genentech
Omid Hamid
Consultant or Advisory Role - Genentech
Honoraria - Genentech
Research Funding - Genentech
Gerald P. Linette
Honoraria - Bristol-Myers Squibb; Genentech; GlaxoSmithKline
Sigrun Hallmeyer
No relevant relationships to disclose
Rene Gonzalez
Consultant or Advisory Role - Roche
Honoraria - Roche/Genentech
Research Funding - Roche/Genentech
Charles Lance Cowey
Consultant or Advisory Role - Genentech
Honoraria - Genentech
Research Funding - Eisai; Genentech; GlaxoSmithKline; Novartis
Anna C. Pavlick
Consultant or Advisory Role - Roche/Genentech
Honoraria - Roche/Genentech
Fred J. Kudrik
No relevant relationships to disclose
David H. Lawson
Consultant or Advisory Role - Roche
Kim Allyson Margolin
Honoraria - Roche/Genentech
Antoni Ribas
Consultant or Advisory Role - Roche/Genentech
David F. McDermott
Consultant or Advisory Role - Bristol-Myers Squibb; Genentech; Prometheus
James L. Khatcheressian
No relevant relationships to disclose
Keith T. Flaherty
Consultant or Advisory Role - Roche/Genentech
Bann-Mo Day
Employment or Leadership Position - Roche/Genentech
Stock Ownership - Roche/Genentech
Rolf Gerhard Linke
Employment or Leadership Position - Roche/Genentech
Stock Ownership - Roche/Genentech
John D. Hainsworth
No relevant relationships to disclose